Evidence map›Paper›PMID 42889800›Full record

ArticleEFSA journal. European Food Safety Authority2026

Assessment of genetically modified maize Bt11 × MIR162 × MON 89034 × NK603 (application GMFF-2025-33624).

EFSA Panel on Genetically Modified Organisms (GMO), Josep Casacuberta, Francisco Barro, Albert Braeuning, Ruud de Maagd, Michelle M Epstein, Thomas Frenzel, Jean-Luc Gallois, Frits Koning, Antoine Messéan and 21 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

EFSA Panel on Genetically Modified Organisms (GMO)
Josep Casacuberta
Francisco Barro
Albert Braeuning
Ruud de Maagd
Michelle M Epstein
Thomas Frenzel
Jean-Luc Gallois
Frits Koning
Antoine Messéan
F Javier Moreno
Fabien Nogué
Giovanni Savoini
Alan H Schulman
Christoph Tebbe
Eve Veromann
Elisabeth Waigmann
Michele Ardizzone
Giacomo De Sanctis
Antonio Fernandez Dumont
Andrea Gennaro
José Ángel Gómez Ruiz
Tilemachos Goumperis
Sara Jacchia
Dafni Maria Kagkli
Paolo Lenzi
Ana M Camargo
Franco Maria Neri
Tommaso Raffaello
Alice Branchi
Arianna Ferrari

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically modified maize Bt11 × MIR162 × MON 89034 × NK603 was developed by crossing to combine four single events: Bt11, MIR162, MON 89034 and NK603. The maize Bt11 × MIR162 × MON 89034 × NK603 expresses the Cry1Ab, PAT, Vip3Aa20, PMI, Cry1A.105, Cry2Ab2, CP4 EPSPS and CP4 EPSPS L214P proteins to confer protection against certain lepidopteran pests, tolerance to glufosinate- and glyphosate-containing herbicides and to be used as a selectable marker. The GMO Panel previously assessed the four single maize events and seven of the sub-combinations and did not identify safety concerns. No new data on the single maize events or the assessed sub-combinations were identified that could lead to modification of the original conclusions on their safety. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single maize events and of the newly expressed proteins in the four-event stack does not give rise to food and feed safety and nutritional concerns. The GMO Panel concludes that the four-event stack, as described in this application, is as safe as the non-GM comparator and non-GM reference varieties tested, and no post-market monitoring of food/feed is considered necessary. In the case of release of processed four-event stack or accidental spillage of viable GM maize seeds into the environment, this would not raise environmental safety concerns. The GMO Panel assessed the likelihood of interactions among the single events in three of the maize sub-combinations not previously assessed and concludes that these are expected to be as safe as the single events, the previously assessed sub-combinations and the four-event stack. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of the four-event stack and of its sub-combinations. The GMO Panel concludes that maize Bt11 × MIR162 × MON 89034 × NK603 and its sub-combinations are as safe as its non-GM comparator and the tested non-GM reference varieties with respect to potential effects on human and animal health and the environment.

Indexed as

genetic engineeringGMherbicide toleranceimport and processinginsect protectionmaize (Zea mays)

Identifiers

PMID42889800
PMCPMC13670140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.